J. Metz et al., THE SIGNIFICANCE OF SUBNORMAL SERUM VITAMIN-B-12 CONCENTRATION IN OLDER-PEOPLE - A CASE-CONTROL STUDY, Journal of the American Geriatrics Society, 44(11), 1996, pp. 1355-1361
OBJECTIVES: To determine the clinical significance of subnormal serum
vitamin B-12 concentration in older people by comparing the hematologi
cal, neurological, and biochemical findings in patients with subnormal
serum B-12 with a control group with normal B-12 levels. DESIGN: Clin
ical and laboratory assessment of hospital patients selected to repres
ent a wide range of serum B-12 levels. SETTING: Patients in the medica
l wards of two hospitals, one a general hospital and the other a geria
tric hospital. PARTICIPANTS: Ninety-four older patients, 43 with subno
rmal (<150 pmol/L) and 51 with normal serum homocysteine were signific
antly different in the low serum B-12 compared with the control group.
There was a significant correlation between serum B-12 and homocystei
ne levels. Eighty-eight percent of patients in the test group compared
with 76% in the control group showed at least one of the following; e
levated serum total homocysteine, neutrophil hypersegmentation, or ele
vated MCV. This overlap was much reduced when patients with borderline
values for serum B-12 (150-250 pmol/L) were included in the low B-12
group. Most of the older subjects had little or no B-12 on transcobala
min II, irrespective of the serum B-12 level. CONCLUSION: Almost 90% o
f older patients with serum B-12 < 150 pmol/L show evidence of tissue
vitamin B-12 deficiency. Deficiency becomes manifest in older patients
at relatively higher concentrations of serum B-12 than in younger sub
jects, possibly because of lower levels of holotranscobalamin II in th
e older patients.